• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

直肠癌 5 年生存率与淋巴结状态的概述。

An Overview of Five-Year Survival in Rectal Cancer in Relation to Lymph Node Status.

出版信息

Chirurgia (Bucur). 2020 Nov-Dec;115(6):747-755. doi: 10.21614/chirurgia.115.6.747.

DOI:10.21614/chirurgia.115.6.747
PMID:33378633
Abstract

Lymph node metastasis is regarded as an important prognostic factor for predicting disease recurrence and survival in patients with colorectal cancer. Several studies suggest that the lymph node ratio has a greater importance in survival than the number of metastatic lymph nodes. The scope of this study is to examine the 5-year survival of rectal cancer patients, examining several prognostic factors with emphasis on lymph node status. Material and A retrospective study was conducted at single surgical clinic from Romania, using data from patients who have been treated for rectal cancer between January 2009 and December 2014. Patient present status and regarding the multimodal treatment was assessed through telephonic method, data was extracted from the electronic database of the clinic and histopathological reports. A total number of 144 patients affected by rectal cancer were assessed. Statistical analysis of the variables showed that age (p=0.001), T stage(p=0.049), N stage (p=0.005), LNR (p=0.006), type of surgery (p 0.001), presence of vascular invasion (p 0.001), metastases (p 0.001), to be significant prognostic factors for survival. The 5-year survival of the patients we included in the study was 63,9%. Nodal status, expressed by lymph node ratio proved to be a significant prognostic factor of patient survival.

摘要

淋巴结转移被认为是预测结直肠癌患者疾病复发和生存的重要预后因素。有几项研究表明,在生存方面,淋巴结比率比转移淋巴结的数量更重要。本研究的范围是检查直肠癌患者的 5 年生存率,重点检查几个预后因素,包括淋巴结状态。

材料和方法

本研究是在罗马尼亚的一家单一外科诊所进行的回顾性研究,使用了 2009 年 1 月至 2014 年 12 月期间接受直肠癌治疗的患者的数据。通过电话方法评估患者的当前状况和多模式治疗情况,从诊所的电子数据库和组织病理学报告中提取数据。共评估了 144 例直肠癌患者。对变量的统计分析表明,年龄(p=0.001)、T 分期(p=0.049)、N 分期(p=0.005)、LNR(p=0.006)、手术类型(p<0.001)、血管侵犯(p<0.001)、转移(p<0.001)均为生存的显著预后因素。

我们纳入研究的患者 5 年生存率为 63.9%。淋巴结比率表示的淋巴结状态被证明是患者生存的重要预后因素。

相似文献

1
An Overview of Five-Year Survival in Rectal Cancer in Relation to Lymph Node Status.直肠癌 5 年生存率与淋巴结状态的概述。
Chirurgia (Bucur). 2020 Nov-Dec;115(6):747-755. doi: 10.21614/chirurgia.115.6.747.
2
Lymph node ratio and surgical quality are strong prognostic factors of rectal cancer: results from a single referral centre.淋巴结比率和手术质量是直肠癌的重要预后因素:来自单一转诊中心的结果。
Colorectal Dis. 2016 Jun;18(6):O175-84. doi: 10.1111/codi.13362.
3
Comparison of three classifications for lymph node evaluation in patients undergoing total mesorectal excision for rectal cancer.直肠癌全直肠系膜切除患者淋巴结评估三种分类方法的比较。
Langenbecks Arch Surg. 2018 Jun;403(4):451-462. doi: 10.1007/s00423-018-1662-5. Epub 2018 Mar 9.
4
lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.在接受全直肠系膜切除术后进行放化疗的Ⅲ期直肠癌患者中,淋巴结比率作为一种预后因素。
Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):796-802. doi: 10.1016/j.ijrobp.2008.08.065. Epub 2009 Mar 14.
5
[A single center retrospective study on surgical efficacy of T3NxM0 middle-low rectal cancer without neoadjuvant therapy].一项关于未行新辅助治疗的T3NxM0中低位直肠癌手术疗效的单中心回顾性研究
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Jan 25;22(1):66-72.
6
[Prognostic value of lymph node ratio in survival of patients with stage III rectal cancer].[淋巴结比率对Ⅲ期直肠癌患者生存的预后价值]
Zhonghua Zhong Liu Za Zhi. 2012 Jul;34(7):506-9. doi: 10.3760/cma.j.issn.0253-3766.2012.07.007.
7
[The association of metastasis-related indexes of lymph nodes and the prognosis of stage N2b colorectal cancer patients].[淋巴结转移相关指标与N2b期结直肠癌患者预后的相关性]
Zhonghua Zhong Liu Za Zhi. 2018 Sep 23;40(9):679-683. doi: 10.3760/cma.j.issn.0253-3766.2018.09.008.
8
Lymph node ratio is an independent prognostic factor in node positive rectal cancer patients treated with preoperative chemoradiotherapy followed by curative resection.淋巴结比率是接受术前放化疗后行根治性切除的淋巴结阳性直肠癌患者的独立预后因素。
Asian Pac J Cancer Prev. 2014;15(13):5365-9. doi: 10.7314/apjcp.2014.15.13.5365.
9
Prognostic Value of Lymph Node Ratio in Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy Followed by Total Mesorectal Excision.术前放化疗联合全直肠系膜切除术后局部晚期直肠癌患者淋巴结比率的预后价值
Medicine (Baltimore). 2016 Mar;95(9):e2988. doi: 10.1097/MD.0000000000002988.
10
Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: a prospective study.III 期直肠癌中转移性淋巴结比率是一个有价值的预后因素,即使检出的淋巴结少于 12 个:一项前瞻性研究。
Am J Surg. 2014 Jun;207(6):824-31. doi: 10.1016/j.amjsurg.2013.07.022. Epub 2013 Oct 8.

引用本文的文献

1
Association of clinicopathological factor with lymph node metastasis in rectal cancer patients: a retrospective cohort study.直肠癌患者临床病理因素与淋巴结转移的相关性:一项回顾性队列研究。
BMC Gastroenterol. 2025 May 12;25(1):358. doi: 10.1186/s12876-025-03960-6.
2
Effect of Tumor Regression Grade on Survival and Disease-Free Interval in Patients Operated on for Locally Advanced Rectal Cancer.肿瘤退缩分级对局部进展期直肠癌手术患者生存及无病间期的影响
Cancers (Basel). 2024 May 8;16(10):1797. doi: 10.3390/cancers16101797.
3
Beyond the Horizon: Unveiling the Frontiers of Rectal Cancer Research and Treatment.
超越地平线:揭示直肠癌研究与治疗的前沿领域。
Cureus. 2023 Nov 14;15(11):e48796. doi: 10.7759/cureus.48796. eCollection 2023 Nov.
4
Not all Rectal Cancer Patients Could Benefit From the Surgery on the Primary Site.并非所有直肠癌患者都能从原发灶手术中获益。
Cancer Control. 2023 Jan-Dec;30:10732748231180056. doi: 10.1177/10732748231180056.
5
A New Nomogram for Predicting the Postoperative Overall Survival in Patients with Middle-Aged and Elderly Rectal Cancer: A Single Center Retrospective Study in Chinese Population.一种预测中老年直肠癌患者术后总生存期的新列线图:中国人群单中心回顾性研究
Int J Gen Med. 2022 May 25;15:5197-5209. doi: 10.2147/IJGM.S365947. eCollection 2022.